3,4-dihydroxyphenylglycol has been researched along with Huntington Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezprozvanny, I; Chan, EY; Hayden, MR; Maximov, A; Tang, TS; Tu, H; Wang, Z; Wellington, CL | 1 |
Bezprozvanny, I; Chan, EY; Hayden, MR; Orban, PC; Tang, TS; Tu, H | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylglycol and Huntington Disease
Article | Year |
---|---|
Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1.
Topics: Action Potentials; Animals; Blotting, Western; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Cerebellum; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fura-2; Green Fluorescent Proteins; Humans; Huntingtin Protein; Huntington Disease; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Lipid Bilayers; Luminescent Proteins; Methoxyhydroxyphenylglycol; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Peptide Fragments; Plasmids; Protein Binding; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Time Factors; Two-Hybrid System Techniques | 2003 |
HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5-trisphosphate-induced Ca release in primary culture of striatal medium spiny neurons.
Topics: Animals; Calcium; Cells, Cultured; Corpus Striatum; Huntington Disease; Inositol 1,4,5-Trisphosphate; Kinetics; Lipid Bilayers; Membrane Glycoproteins; Membrane Transport Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Serotonin Plasma Membrane Transport Proteins | 2004 |